4basebio (LON:4BB) Stock Price Down 2.1% – Time to Sell?

Shares of 4basebio PLC (LON:4BB) dropped 2.1% on Thursday . The company traded as low as GBX 1,185 ($14.67) and last traded at GBX 1,185 ($14.67). Approximately 3,034 shares changed hands during trading, a decline of 31% from the average daily volume of 4,379 shares. The stock had previously closed at GBX 1,210 ($14.98).

4basebio Stock Down 2.1 %

The firm has a 50-day moving average of GBX 1,251.16 and a two-hundred day moving average of GBX 1,376.71. The stock has a market capitalization of £151.80 million, a price-to-earnings ratio of -1,519.23 and a beta of 1.09. The company has a quick ratio of 3.52, a current ratio of 2.73 and a debt-to-equity ratio of 201.47.

Insider Activity

In related news, insider Heikki Lanckriet bought 46,500 shares of the firm’s stock in a transaction on Friday, November 15th. The stock was bought at an average price of GBX 1,325 ($16.40) per share, with a total value of £616,125 ($762,625.32). 68.44% of the stock is owned by corporate insiders.

About 4basebio

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.

Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients.